Location: Lake CIty
404 NW Hall of Fame Drive
Lake City, FL 32055
Tel: (386) 868-5625
This is a phase 2 study evaluating the efficacy and safety of a low and high dose of study LX9211 compared to placebo in patients with moderate to severe diabetic peripheral neuropathy.
Condition: Diabetic Peripheral Neuropathy
The purpose of this study is to evaluate the effectiveness of 2 doses or 3 doses of GSK’s licenced meningococcal group B Bexsero (rMenB+OMV NZ) vaccine and of 2 doses of GSK’s investigational combined meningococcal (MenABCWY) vaccine (GSK3536819A) in healthy adolescents and young adults.
Location(s): Lake CIty
A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease